Search Results 1-12 of 12

1. 1. H.Amdt.722   — 116th Congress (2019-2020) Description: An amendment numbered 12 printed in Part B of House Report 116-334 to increase funding for clinical trials at NIH and ban the use of spread pricing by PBMs as it relates to Medicaid. Sponsor: Rep. Houlahan, Chrissy [D-PA-6] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Houlahan amendment (A012) Agreed to by voice vote. (All Actions)
2. 1. H.Amdt.722   — 116th Congress (2019-2020) Description: An amendment numbered 12 printed in Part B of House Report 116-334 to increase funding for clinical trials at NIH and ban the use of spread pricing by PBMs as it relates to Medicaid. Sponsor: Rep. Houlahan, Chrissy [D-PA-6] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Houlahan amendment (A012) Agreed to by voice vote. (All Actions)
3. 2. H.Amdt.721   — 116th Congress (2019-2020) Description: An amendment numbered 11 printed in Part B of House Report 116-334 to allow the Veterans Administration to benefit from Maximum Fair Pricing guidelines. Sponsor: Rep. Cunningham, Joe [D-SC-1] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Cunningham amendment (A011) Agreed to by recorded vote: 234 - 192 (Roll no. 680). (All Actions)
4. 2. H.Amdt.721   — 116th Congress (2019-2020) Description: An amendment numbered 11 printed in Part B of House Report 116-334 to allow the Veterans Administration to benefit from Maximum Fair Pricing guidelines. Sponsor: Rep. Cunningham, Joe [D-SC-1] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Cunningham amendment (A011) Agreed to by recorded vote: 234 - 192 (Roll no. 680). (All Actions)
5. 3. H.Amdt.720   — 116th Congress (2019-2020) Description: An amendment numbered 10 printed in Part B of House Report 116-334 to clarify that federal employee health plans are covered by the price reduction provisions of the bill. Sponsor: Rep. Luria, Elaine G. [D-VA-2] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Luria amendment (A010) Agreed to by recorded vote: 231 - 192 (Roll no. 679). (All Actions)
6. 3. H.Amdt.720   — 116th Congress (2019-2020) Description: An amendment numbered 10 printed in Part B of House Report 116-334 to clarify that federal employee health plans are covered by the price reduction provisions of the bill. Sponsor: Rep. Luria, Elaine G. [D-VA-2] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Luria amendment (A010) Agreed to by recorded vote: 231 - 192 (Roll no. 679). (All Actions)
7. 4. H.Amdt.719   — 116th Congress (2019-2020) Description: An amendment numbered 9 printed in Part B of House Report 116-334 to require drug companies to disclose truthful and non-misleading pricing information about prescription drugs and biological products when they advertise these products directly to consumers. Sponsor: Rep. Finkenauer, Abby [D-IA-1] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Finkenauer amendment (A009) Agreed to by voice vote. (All Actions)
8. 4. H.Amdt.719   — 116th Congress (2019-2020) Description: An amendment numbered 9 printed in Part B of House Report 116-334 to require drug companies to disclose truthful and non-misleading pricing information about prescription drugs and biological products when they advertise these products directly to consumers. Sponsor: Rep. Finkenauer, Abby [D-IA-1] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Finkenauer amendment (A009) Agreed to by voice vote. (All Actions)
9. 5. H.Amdt.718   — 116th Congress (2019-2020) Description: An amendment numbered 8 printed in Part B of House Report 116-334 to establish a grant program for states to reduce the burdens associated with health care administrative work and reduces HHS administrative costs by 50% over 10 years. Sponsor: Rep. Axne, Cynthia [D-IA-3] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Axne amendment (A008) Agreed to by voice vote. (All Actions)
10. 5. H.Amdt.718   — 116th Congress (2019-2020) Description: An amendment numbered 8 printed in Part B of House Report 116-334 to establish a grant program for states to reduce the burdens associated with health care administrative work and reduces HHS administrative costs by 50% over 10 years. Sponsor: Rep. Axne, Cynthia [D-IA-3] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Axne amendment (A008) Agreed to by voice vote. (All Actions)
11. 6. H.Amdt.717   — 116th Congress (2019-2020) Description: An amendment numbered 7 printed in Part B of House Report 116-334 to require an HHS study to identify conditions without an FDA-approved treatment where the development of a treatment would fill an unmet medical need for a serious or life-threatening condition or rare disease. Requires HHS to identify appropriate incentives that would lead to the development of such treatments. Sponsor: Rep. Gottheimer, Josh [D-NJ-5] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Gottheimer amendment (A007) Agreed to by recorded vote: 380 - 45 (Roll no. 678). (All Actions)
12. 6. H.Amdt.717   — 116th Congress (2019-2020) Description: An amendment numbered 7 printed in Part B of House Report 116-334 to require an HHS study to identify conditions without an FDA-approved treatment where the development of a treatment would fill an unmet medical need for a serious or life-threatening condition or rare disease. Requires HHS to identify appropriate incentives that would lead to the development of such treatments. Sponsor: Rep. Gottheimer, Josh [D-NJ-5] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Gottheimer amendment (A007) Agreed to by recorded vote: 380 - 45 (Roll no. 678). (All Actions)
13. 7. H.Amdt.716   — 116th Congress (2019-2020) Description: An amendment numbered 6 printed in Part B of House Report 116-334 to express the Sense of Congress regarding the impact of the high cost of prescription drugs on communities of color and persons living in rural or sparsely populated areas of the United States. Sponsor: Rep. Kennedy, Joseph P., III [D-MA-4] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Kennedy amendment (A006) Agreed to by voice vote. (All Actions)
14. 7. H.Amdt.716   — 116th Congress (2019-2020) Description: An amendment numbered 6 printed in Part B of House Report 116-334 to express the Sense of Congress regarding the impact of the high cost of prescription drugs on communities of color and persons living in rural or sparsely populated areas of the United States. Sponsor: Rep. Kennedy, Joseph P., III [D-MA-4] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Kennedy amendment (A006) Agreed to by voice vote. (All Actions)
15. 8. H.Amdt.715   — 116th Congress (2019-2020) Description: An amendment numbered 5 printed in Part B of House Report 116-334 to create a grant program within HHS for hospitals located in rural and medically underserved areas, including Critical Access Hospitals, to cover the start-up costs for establishing a Graduate Medical Education (GME) program or a partnership with a hospital that has an existing program. It would include a reporting requirement for GAO to analyze whether residents continue to practice in a rural or medically underserved area after completing their training. Sponsor: Rep. O'Halleran, Tom [D-AZ-1] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the O'Halleran amendment (A005) Agreed to by recorded vote: 351 - 73 (Roll no. 677). (All Actions)
16. 8. H.Amdt.715   — 116th Congress (2019-2020) Description: An amendment numbered 5 printed in Part B of House Report 116-334 to create a grant program within HHS for hospitals located in rural and medically underserved areas, including Critical Access Hospitals, to cover the start-up costs for establishing a Graduate Medical Education (GME) program or a partnership with a hospital that has an existing program. It would include a reporting requirement for GAO to analyze whether residents continue to practice in a rural or medically underserved area after completing their training. Sponsor: Rep. O'Halleran, Tom [D-AZ-1] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the O'Halleran amendment (A005) Agreed to by recorded vote: 351 - 73 (Roll no. 677). (All Actions)
17. 9. H.Amdt.714   — 116th Congress (2019-2020) Description: An amendment numbered 4 printed in Part B of House Report 116-334 to require another Senate confirmed officer with HHS to carry out the negotiation duties should the Secretary of HHS have a conflict of interest. The General Counsel of HHS would be responsible for identifying these conflicts. Sponsor: Rep. Kennedy, Joseph P., III [D-MA-4] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Kennedy amendment (A004) Agreed to by voice vote. (All Actions)
18. 9. H.Amdt.714   — 116th Congress (2019-2020) Description: An amendment numbered 4 printed in Part B of House Report 116-334 to require another Senate confirmed officer with HHS to carry out the negotiation duties should the Secretary of HHS have a conflict of interest. The General Counsel of HHS would be responsible for identifying these conflicts. Sponsor: Rep. Kennedy, Joseph P., III [D-MA-4] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Kennedy amendment (A004) Agreed to by voice vote. (All Actions)
19. 10. H.Amdt.713   — 116th Congress (2019-2020) Description: An amendment numbered 3 printed in Part B of House Report 116-334 to to authorize a pilot program to develop, expand, and enhance the commercialization of biomedical products, and for other purposes. Sponsor: Rep. Peters, Scott H. [D-CA-52] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Peters amendment (A003) Agreed to by voice vote. (All Actions)
20. 10. H.Amdt.713   — 116th Congress (2019-2020) Description: An amendment numbered 3 printed in Part B of House Report 116-334 to to authorize a pilot program to develop, expand, and enhance the commercialization of biomedical products, and for other purposes. Sponsor: Rep. Peters, Scott H. [D-CA-52] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Peters amendment (A003) Agreed to by voice vote. (All Actions)
21. 11. H.Amdt.712   — 116th Congress (2019-2020) Description: An amendment numbered 2 printed in Part B of House Report 116-334 to require CMS to create and implement a measure in the Star Ratings program evaluating Medicare Advantage and Part D plans on how well they provide access to biosimilar drugs. Sponsor: Rep. Tonko, Paul [D-NY-20] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Tonko amendment (A002) Agreed to by voice vote. (All Actions)
22. 11. H.Amdt.712   — 116th Congress (2019-2020) Description: An amendment numbered 2 printed in Part B of House Report 116-334 to require CMS to create and implement a measure in the Star Ratings program evaluating Medicare Advantage and Part D plans on how well they provide access to biosimilar drugs. Sponsor: Rep. Tonko, Paul [D-NY-20] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Tonko amendment (A002) Agreed to by voice vote. (All Actions)
23. 12. H.Amdt.711   — 116th Congress (2019-2020) Description: An amendment numbered 1 printed in Part B of House Report 116-334 to include provisions in the bill related to Medicare Parts B&D, drug price transparency, Medicare Part D benefit redesign, MedPAC, Medicaid, FDA, and revenue provisions. Sponsor: Rep. Walden, Greg [R-OR-2] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Walden amendment (A001) Failed by recorded vote: 201 - 223 (Roll no. 676). (All Actions)
24. 12. H.Amdt.711   — 116th Congress (2019-2020) Description: An amendment numbered 1 printed in Part B of House Report 116-334 to include provisions in the bill related to Medicare Parts B&D, drug price transparency, Medicare Part D benefit redesign, MedPAC, Medicaid, FDA, and revenue provisions. Sponsor: Rep. Walden, Greg [R-OR-2] (Offered 12/12/2019) Latest Action: 12/12/19 On agreeing to the Walden amendment (A001) Failed by recorded vote: 201 - 223 (Roll no. 676). (All Actions)